3.9 Review

GLP-2: What do we know? What are we going to discover?

Journal

REGULATORY PEPTIDES
Volume 194, Issue -, Pages 6-10

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.regpep.2014.09.002

Keywords

GLP-2; GLP-2 receptor; The gastrointestinal tract; The enteric nervous system

Funding

  1. MIUR, Italy

Ask authors/readers for more resources

Glucagon-like peptide 2 [GLP-2] is a 33-amino add peptide released from the mucosal enteroendocrine L-cells of the intestine. The actions of GLP-2 are transduced by the GLP-2 receptor [GLP-2R], which is localized in the neurons of the enteric nervous system but not in the intestinal epithelium, indicating an indirect mechanism of action. GLP-2 is well known for its trophic role within the intestine and interest in GLP-2 is now reviving based on the approval of the GLP-2R agonist for treatment of short bowel syndrome [SBS]. Recently it also seems to be involved in glucose homeostasis. The aim of this review is to outline the importance of neuroendocrine peptides, specifically of GLP-2 in the enteric modulation of the gastrointestinal function and to focus on new works in order to present an innovative picture of GLP-2. (C) 2014 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.9
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available